EASL is the largest professional body in Europe devoted to liver health. EASL’s overarching goal is to spread knowledge and expertise in best practices and the latest scientific breakthroughs in the field of hepatology. It also advocates at national, European,…
This October 2022, in honour of Liver Cancer Awareness Month, EASL participated in organising two important advocacy events aimed at identifying and implementing strategies to enhance awareness of liver cancer and engage key policymakers at the EU level.
27 May 2022 This European Week Against Cancer (#EWAC22), EASL is tackling liver cancer by publishing a Policy Statement on liver cancer screening. This Policy Statement is written by EASL Policy and Public Health Committee member, Prof. Peter Jepsen, with…
12 April 2022 EASL has recently published its first ever accessible lay summary on how to tackle non-alcoholic fatty liver disease (NAFLD). This 20-page summary is intended for the general public, people at risk of – or already living with…
7 April 2022 On World Health Day, EASL explores the complex relationship between the well-being of the planet and that of our livers.
25 March 2022 On 15 March 2022, the Members of Parliament (MEP) Friends of the Liver Group (hereafter “the Group”), coordinated by EASL was relaunched online. To mark the occasion, a webinar was held to discuss the increasing burden of…
20 December 2021 On 22 November 2021, EASL held its annual Patient Forum on the topic: health literacy to empower patients and address inequities. We collaborated with five members of our Patient Synergies network to bring together the expertise of…
9 November 2021 With October being a month dedicated to promoting liver cancer awareness, EASL participated in numerous relevant activities. EASL leadership played a key role notably in two high-level advocacy events, coming to the heart of advocacy. The European…
17 September 2021 On 14 September 2021, EASL, in its role as non-state actor in official relations with the World Health Organization (WHO), provided a joint statement on matters of considerable importance in liver care: primary health care and keeping viral hepatitis elimination clearly on the agenda.
